SUPRAX Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Suprax patents expire, and when can generic versions of Suprax launch?
Suprax is a drug marketed by Lupin Ltd, Lederle, and Lupin Pharms. and is included in eight NDAs. There is one patent protecting this drug and one Paragraph IV challenge.
This drug has two patent family members in two countries.
The generic ingredient in SUPRAX is cefixime. There are fourteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cefixime profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Suprax
A generic version of SUPRAX was approved as cefixime by AUROBINDO PHARMA LTD on April 14th, 2015.
Summary for SUPRAX
International Patents: | 2 |
US Patents: | 1 |
Applicants: | 3 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 49 |
Clinical Trials: | 5 |
Patent Applications: | 5,251 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SUPRAX |
What excipients (inactive ingredients) are in SUPRAX? | SUPRAX excipients list |
DailyMed Link: | SUPRAX at DailyMed |


Recent Clinical Trials for SUPRAX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
PT Pharma Metric Labs | N/A |
PT Bernofarm | N/A |
University of California, Los Angeles | Phase 2 |
Pharmacology for SUPRAX
Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for SUPRAX
US Patents and Regulatory Information for SUPRAX
SUPRAX is protected by one US patents.
Patents protecting SUPRAX
Pharmaceutical compositions of cefixime
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHODS FOR TREATING BACTERIAL INFECTIONS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lupin Ltd | SUPRAX | cefixime | CAPSULE;ORAL | 203195-001 | Jun 1, 2012 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Lupin Ltd | SUPRAX | cefixime | TABLET, CHEWABLE;ORAL | 065380-002 | Oct 25, 2010 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lupin Pharms | SUPRAX | cefixime | FOR SUSPENSION;ORAL | 065129-001 | Feb 23, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lupin Ltd | SUPRAX | cefixime | TABLET, CHEWABLE;ORAL | 065380-003 | Oct 25, 2010 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lederle | SUPRAX | cefixime | FOR SUSPENSION;ORAL | 050622-001 | Apr 28, 1989 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lupin Ltd | SUPRAX | cefixime | FOR SUSPENSION;ORAL | 202091-001 | Feb 20, 2013 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for SUPRAX
See the table below for patents covering SUPRAX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 2007119249 | ⤷ Try a Trial | |
Germany | 112007000920 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |